{"title":"Immunogenetic factors in the survival of ovarian transplants.","authors":"M B Goldman","doi":"10.1097/00007890-197405000-00013","DOIUrl":null,"url":null,"abstract":"SUMMARY Genetic and immunological factors which affect the survival of heterotopically grafted ovaries were studied in inbred mice. It was shown that when donor and recipient differed by the K region antigen, H-2.31, transplants had a median function time (MFT) of 9.5 days as determined by vaginal smears and confirmed by histological examination. Injections of recipients with mouse anti-H-2.31 serum increased the MFT to 18.5 days (passive enhancement), but pretreatment of hosts with lyophilized donor lymphoid tissue (active enhancement) could not be shown to effect graft survival significantly. In experiments where donor and recipient differed by a single D region antigen, H-2.32, transplants had an MFT of 13.5 days. When an H-4 difference was studied, ovarian grafts had an MFT of 15.5 days but 2 out of 14 grafts were still functioning 50 days after transplantation. Nine out of nine ovarian grafts in a combination involving an H-l difference were likewise functioning 50 clays after transplantation. These results show that ovarian implants in mice behave as skin grafts and heart transplants—which have short-term survival that can be passively enhanced—rather than as kidney transplants, which have survived indefinitely.","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":"17 5","pages":"518-23"},"PeriodicalIF":5.0000,"publicationDate":"1974-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/00007890-197405000-00013","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/00007890-197405000-00013","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 4
Abstract
SUMMARY Genetic and immunological factors which affect the survival of heterotopically grafted ovaries were studied in inbred mice. It was shown that when donor and recipient differed by the K region antigen, H-2.31, transplants had a median function time (MFT) of 9.5 days as determined by vaginal smears and confirmed by histological examination. Injections of recipients with mouse anti-H-2.31 serum increased the MFT to 18.5 days (passive enhancement), but pretreatment of hosts with lyophilized donor lymphoid tissue (active enhancement) could not be shown to effect graft survival significantly. In experiments where donor and recipient differed by a single D region antigen, H-2.32, transplants had an MFT of 13.5 days. When an H-4 difference was studied, ovarian grafts had an MFT of 15.5 days but 2 out of 14 grafts were still functioning 50 days after transplantation. Nine out of nine ovarian grafts in a combination involving an H-l difference were likewise functioning 50 clays after transplantation. These results show that ovarian implants in mice behave as skin grafts and heart transplants—which have short-term survival that can be passively enhanced—rather than as kidney transplants, which have survived indefinitely.
期刊介绍:
The official journal of The Transplantation Society, and the International Liver Transplantation Society, Transplantation is published monthly and is the most cited and influential journal in the field, with more than 25,000 citations per year.
Transplantation has been the trusted source for extensive and timely coverage of the most important advances in transplantation for over 50 years. The Editors and Editorial Board are an international group of research and clinical leaders that includes many pioneers of the field, representing a diverse range of areas of expertise. This capable editorial team provides thoughtful and thorough peer review, and delivers rapid, careful and insightful editorial evaluation of all manuscripts submitted to the journal.
Transplantation is committed to rapid review and publication. The journal remains competitive with a time to first decision of fewer than 21 days. Transplantation was the first in the field to offer CME credit to its peer reviewers for reviews completed.
The journal publishes original research articles in original clinical science and original basic science. Short reports bring attention to research at the forefront of the field. Other areas covered include cell therapy and islet transplantation, immunobiology and genomics, and xenotransplantation.